Sympathetic Nervous System Diseases

2

Review clinical trials related to Sympathetic Nervous System Diseases. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Sympathetic Nerve Activity Predictors in Patients With Chronic Obstructive Pulmonary Disease

The project will be pursued in our respiratory, autonomic nervous system physiology laboratory (Respiratory, autonomic nervous system physiology laboratory, Department of Pneumology and Intensive Care Medicine, RWTH Aachen University Hospital; Head of Department: Professor Michael Dreher). Overactivity of the sympathetic nerve activity (SNA) axis with "centrally" increased heart rate and peripheral vasoconstriction is a known phenomenon in patients with systolic heart failure (HF) and has recently been described in patients with primary lung disease as seen in chronic obstructive pulmonary disease (COPD). However, systematic analyses on this clinically relevant topic are currently lacking. Thus, using a comprehensive, multimodal approach and state-of-the-art technology, this research project is designed to determine the extent and nature of increased SNA in COPD (AIM 1) and evaluate the underlying mechanisms (AIM 2). The project will address the following hypotheses: 1. In COPD, concomitant obstructive sleep apnea is independently associated with increased SNA. 2. Precapillary pulmonary hypertension (PH), inspiratory muscle dysfunction and systemic inflammation describe a COPD phenotype characterised by increased SNA with a different subtype.

Participants needed: 135
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: RWTH Aachen UniversityUpdated: Jan 28, 2026Locations: 1
Eligibility criteria

Age ≥ 18 [+1]

Atrial fibrillation [+3]

Status: Recruiting

Hydroxyephedrine PET/CT in Sympathetic Nervous System Disease

To evaluate the potential usefulness of 11C/18F-HED positron emission tomography/ computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various Tau-related disease patients.

Participants needed: 500
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: Tianjin Medical UniversityUpdated: Apr 30, 2025Locations: 1Duration: 7 Days
Eligibility criteria

(i) adult patients (aged 18 years or order); (ii) patients with suspected or new...

(i) patients with non-malignant lesions; (ii) patients with pregnancy; (iii) the...